Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) — The “Spatial Transcriptomics & Genomics Market – Global Outlook & Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.
The Spatial Transcriptomics & Genomics Market was valued at USD 383.93 million in 2024, and is projected to reach USD 1 billion by 2030, rising at a CAGR of 17.4%.
The global spatial transcriptomics and genomics market is highly competitive, driven by rapid advancements in technology and increasing demand for precision medicine. This dynamic market is characterized by the presence of established players, emerging startups, and ongoing innovation aimed at addressing complex biological questions through spatially resolved omics techniques. The competition is fueled by the need for advanced tools and solutions to enhance research capabilities, accelerate drug discovery, and improve diagnostics.
Companies like 10x Genomics, Bio-techne, NanoString Technologies, and Illumina are major players in the global spatial transcriptomics and genomics market that have established strong footholds through innovative technologies and comprehensive product portfolios. These leaders focus on offering robust solutions like 10x Genomics’ Visium platform and NanoString’s GeoMx Digital Spatial Profiler, which provide high-resolution spatial mapping of gene expression. Furthermore, strategic acquisitions, such as 10x Genomics acquiring ReadCoor and Cartana, are common to expand capabilities in spatial genomics and transcriptomics. Also, numerous startups, such as Resolve Biosciences and Spatial Genomics, are entering the spatial transcriptomics and genomics market with disruptive technologies.
MARKET TRENDS & DRIVERS
Increasing Use of Spatial Omics for Biomarker Identification
By enabling detailed mapping of molecular interactions within tissues, spatial omics offer a powerful approach to discovering novel biomarkers, advancing precision medicine, and improving therapeutic outcomes. With rapid technological advancements and a growing interest in personalized healthcare, the spatial transcriptomics and genomics market is positioned for substantial growth. As more researchers, pharmaceutical companies, and diagnostics firms adopt spatial omics for biomarker discovery, this emerging field will likely play a pivotal role in shaping the future of healthcare.
Emerging Potential of Spatial Genomic Analysis in Cancer Diagnosis
The emerging potential of spatial genomic analysis in cancer diagnosis represents a transformative development in the field of oncology, offering unprecedented precision in tumor profiling and personalized treatment strategies. This trend is poised to drive growth in the global spatial transcriptomics and genomics market, opening new avenues for innovation in diagnostics, biomarker discovery, and targeted therapy development. As the technology evolves and becomes more cost-effective, spatial genomics will likely play a central role in revolutionizing cancer diagnosis and treatment on a global scale.
Increasing Adoption of Spatial Genomics and Transcriptomics Technologies
With expanding applications in cancer research, neuroscience, precision medicine, and more, these technologies are revolutionizing how scientists understand biological processes. As AI and machine learning continue to enhance data analysis and as collaborations boost research capabilities, the market is expected to grow further. By addressing current challenges and building on technological advancements, spatial genomics, and transcriptomics are set to play an increasingly critical role in modern biomedical research and clinical practice, shaping the future of medicine.
Growth in Preference Toward Personalized Medicines
The preference for personalized medicine is a major driver of the global spatial transcriptomics and genomics market, highlighting the increasing need for highly specialized tools to analyze gene expression in spatial contexts. With advances in technology and a growing focus on individualized patient care, spatial techniques are poised to transform disease research, drug development, and clinical diagnostics. As spatial genomics becomes more accessible and its applications in personalized medicine expand, it will play a pivotal role in the future of healthcare, enabling treatments that are not only more effective but also more aligned with each patient’s unique genetic and cellular landscape.
Rise in Prevalence of Genetic Disorders
The rising prevalence of genetic disorders has underscored the need for innovative diagnostic and therapeutic tools, which spatial transcriptomics and genomics are well-positioned to address. By providing a detailed spatial understanding of gene expression and genetic mutations within tissues, these technologies allow researchers to delve deeper into the cellular mechanics of genetic disorders. As the spatial transcriptomics and genomics market continues to grow, driven by technological advances and the need for precision in genetic disorder research, it holds the potential to revolutionize the diagnosis, treatment, and understanding of numerous genetic diseases, offering hope for improved patient outcomes and enhanced quality of life for individuals affected by genetic disorders.
VENDOR LANDSCAPE
Key Company Profiles
- 10x Genomics
- Bio-Techne
- Illumina
- NanoString (Bruker Spatial Biology)
Other Prominent Vendors
- Akoya Biosciences
- BioSpyder Technologies
- Cantata Bio
- Natera
- RareCyte
- Rebus Biosystems
- Resolve Biosciences GmbH
- S2 Genomics
- Seven Bridges Genomics
- Standard BioTools
- Vizgen
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 362 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $383.93 Million |
| Forecasted Market Value (USD) by 2030 | $1000 Million |
| Compound Annual Growth Rate | 17.4% |
| Regions Covered | Global |
Key Topics Covered:
Scope & Coverage
- Market Segment Coverage and Definition
- Market Segmentation by Product Type
- Market Segmentation by Technology
- Market Segmentation by Application
- Market Segmentation by End-user
- Regions & Countries Covered
Market Opportunities & Trends
- Increasing Use of Spatial Omics for Biomarker Identification
- Emerging Potential of Spatial Genomic Analysis in Cancer Diagnosis
- New Product Launches & Developments
Market Growth Enablers
- Increasing Adoption of Spatial Genomics and Transcriptomics Technologies
- Growth in Preference Toward Personalized Medicines
- Rise in Prevalence of Genetic Disorders
Market Restraints
- High Capital Investments
- Technical Complexity and Data Analysis
- Ethical and Regulatory Concerns
For more information about this report visit https://www.researchandmarkets.com/r/9hn8at
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Spatial Transcriptomics & Genomics Market
